Profile data is unavailable for this security.
About the company
Inspiration Healthcare Group plc is a United Kingdom-based global medical technology company providing neonatal intensive care medical devices. The Company provides products to patients around the world which help to improve patient outcomes, whether it is a baby who has been born prematurely, or a patient undergoing surgery. Its areas of care include Acute Care and Infusion Therapies. Its Acute Care products include neonatal, respiratory, auto FiO2, obstetrics and developmental care. It offers a full range of ambulatory infusion pumps, administration sets, accessories, and patient infusion management systems for both hospital and homecare applications. It provides a range of Micrel Medical infusion devices, for various applications such as parenteral nutrition, oncology, immunoglobulin therapy, antibiotic infusion, palliative care, acute pain management, and obstetrics. It is also a manufacturer of specialist pneumatic oxygen-powered life support ventilators.
- Revenue in GBP (TTM)45.20m
- Net income in GBP-11.44m
- Incorporated1998
- Employees214.00
- LocationInspiration Healthcare Group PLC2 Satellite Business VillageCRAWLEY RH10 9NEUnited KingdomGBR
- Phone+44 17 0976 1000Fax+44 17 0976 1066
- Websitehttps://inspirationhealthcaregroup.com/
Peer analysis
| Company | Revenue (TTM) | Net income (TTM) |
|---|---|---|
| Genincode PLC | 2.91m | -4.97m |
| Surgical Innovations Group Plc | 11.92m | -1.44m |
| Cambridge Nutritional Sciences PLC | 8.06m | 1.37m |
| Feedback plc | 885.62k | -7.32m |
| Proteome Sciences plc | 4.53m | -3.33m |
| Rua Life Sciences PLC | 5.17m | -850.00k |
| Verici DX PLC | 1.41m | -5.60m |
| Genedrive PLC | 954.00k | -5.23m |
| Cellbxhealth PLC | 2.62m | -15.78m |
| Abingdon Health PLC | 8.43m | -3.42m |
| Inspiration Healthcare Group PLC | 45.20m | -11.44m |
| Aptamer Group PLC | 1.20m | -2.42m |
| Renalytix PLC | 2.20m | -14.99m |
Institutional shareholders
| Holder | Shares | % Held |
|---|---|---|
| BGF Investment Management Ltd.as of 30 May 2025 | 18.87m | 21.04% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 30 Dec 2024 | 7.37m | 8.22% |
| Liontrust Investment Partners LLPas of 30 May 2025 | 4.14m | 4.62% |
| Octopus Investments Ltd.as of 30 Jun 2024 | 3.80m | 4.24% |
| Stonehage Fleming Investment Management Ltd.as of 30 Sep 2025 | 3.23m | 3.60% |
| Castlefield Investment Partners LLPas of 30 May 2025 | 2.95m | 3.29% |
| BlackRock Investment Management (UK) Ltd.as of 03 Nov 2025 | 2.18m | 2.43% |
| Hargreaves Lansdown Fund Managers Ltd.as of 03 Nov 2025 | 799.00k | 0.89% |
| HSBC Global Asset Management (UK) Ltd.as of 03 Nov 2025 | 765.00k | 0.85% |
| Premier Fund Managers Ltd.as of 31 Jul 2025 | 724.08k | 0.81% |
